Meda: FDA Requests More Information On New Azelastine Formulation

MEDA AB (publ) be an transnational specialty pharma crowd that concentrate by marketing and market-adapted service nurturing. Acquisitions and long-term partnership be essence factor that drive the company's strategy. Meda is indicate subsequent to relevant organisations inwardly 26 province and with greater than 1 500 human resources within marketing and sale. Meda's products are sold in almost 120 countries world-wide. The Meda chop is programmed underneath Large Cap on the OMX Nordic Stock Exchange.